Market revenue in 2023 | USD 1,030.3 million |
Market revenue in 2030 | USD 1,957.8 million |
Growth rate | 9.6% (CAGR from 2023 to 2030) |
Largest segment | Ballon sinus dilation devices |
Fastest growing segment | Functional Endoscopic Sinus Surgery (FESS) Instruments Set |
Historical data | 2016 - 2022 |
Base year | 2023 |
Forecast period | 2024 - 2030 |
Quantitative units | Revenue in USD million |
Market segmentation | Ballon Sinus Dilation Devices, Endoscopes, Sinus Stents/Implants, Functional Endoscopic Sinus Surgery (FESS) Instruments Set |
Key market players worldwide | Medtronic PLC, Smith & Nephew PLC, Stryker Corp, Intersect ENT, Olympus Corp, Johnson & Johnson, TE Connectivity Ltd, SinuSys Corp., InnAccel |
Ballon sinus dilation devices was the largest segment with a revenue share of 48.62% in 2023. Horizon Databook has segmented the U.S. sinus dilation device market based on ballon sinus dilation devices, endoscopes, sinus stents/implants, functional endoscopic sinus surgery (fess) instruments set covering the revenue growth of each sub-segment from 2016 to 2030.
The U.S. accounted for the largest share in the North America sinus dilation devices market. Increasing prevalence of chronic sinusitis is considered to be the major factor driving the market in this region.
In addition, favorable reimbursement policies are expected to further fuel the market growth. With regard to medical reimbursement system in the U.S., around 84% of the population is covered by either public (26%) or private (70%) health insurance. For instance, according to the report published by Acclarent, Inc.
No credit card required*
Name | Profile | # Employees | HQ | Website |
---|
Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our
free plan indefinitely.
Included in Horizon account